NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.68% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.63% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 1.40% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.28% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.28% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.23% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.20% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.16% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.15% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.15% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 1.15% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 1.11% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.10% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.05% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.05% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.04% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.02% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.02% |